| Category Name | Content |
| Name | Plasma Fibroblast Therapy |
| Uses | Non-invasive skin tightening and resurfacing procedure using plasma energy to stimulate fibroblast activity, promote collagen production, and improve fine lines, wrinkles, scars, and skin laxity. |
| Route Of Administration | External application using a plasma pen device that ionizes gas particles to create controlled micro-injuries in the epidermis. |
| Frequency Of Use | Typically performed once every 6-8 weeks, depending on skin healing and treatment goals. A series of 1-3 sessions is recommended for optimal results. |
| Concentration(s) | Plasma energy output varies based on device settings and treatment area: - **Low Energy:** Superficial tightening and fine lines - **Medium Energy:** Moderate wrinkles and skin laxity - **High Energy:** Deep wrinkles, scars, and skin resurfacing |
| Maximum Dosage (Day, Wk) | One treatment per session, per area. Avoid overlapping treatments on the same area within 6-8 weeks to prevent excessive trauma and delayed healing. |
| Contraindications | Pregnancy, breastfeeding, Fitzpatrick skin types IV-VI (high risk of hyperpigmentation), active skin infections, keloid-prone skin, recent sun exposure, use of isotretinoin within the last 6 months, autoimmune skin conditions, or history of poor wound healing. |
| Possible Side Effects | Redness, swelling, pinpoint scabbing, temporary darkening of treated areas (PIH), itching, or rare risk of prolonged erythema and scarring. |
| Compatibility With Other Treatments/Drugs | Avoid combining with aggressive exfoliants, chemical peels, or laser treatments within 4 weeks. Safe to combine with post-procedure healing serums, LED therapy, and exosome therapy for accelerated recovery. |
| Allergies | Assess for hypersensitivity to numbing agents, post-treatment serums, or plasma technology-related compounds. |
| Administration Time | Typically 30-60 minutes per session, including numbing time and plasma application. |
| Dosing/Settings | Standard treatment protocol: - **Spot Size:** 0.3-0.8 mm plasma arc diameter - **Energy Output:** Adjusted per skin type and area - **Treatment Technique:** Grid or dot pattern for controlled micro-injuries |
| Test Spot Requirement | Required for Fitzpatrick III-IV skin types. Perform a small test area 48 hours before full treatment to assess risk of hyperpigmentation. |
| Pre-Treatment Guidelines | - Avoid direct sun exposure, tanning beds, and self-tanners for 4 weeks prior to treatment. - Discontinue retinoids, AHAs, and BHAs for 7 days before treatment. - Ensure skin is clean and free of makeup, lotions, or occlusive products before treatment. - Apply topical numbing cream (lidocaine-based) 30-45 minutes before the procedure. |
| Provider Clearance Guidelines | - Ensure the patient meets all clearance criteria before treatment. - If the patient has a history of hyperpigmentation, pre-treat with hydroquinone or a tyrosinase inhibitor. - Document all clearance decisions in the patient’s medical record. |
| Pre-Treatment Screening Workflow | - Does the patient have a history of keloid formation? (If YES, proceed with caution and document risk counseling) - Has the patient used isotretinoin within the last 6 months? (If YES, contraindicated) - Has the patient had excessive sun exposure recently? (If YES, delay treatment by 2-4 weeks) - Is the patient pregnant or breastfeeding? (If YES, contraindicated) |
| What To Do If Adverse Reaction Occurs | - **Prolonged redness or swelling**: Apply cool compress, recommend post-procedure serums. - **Burns or excessive discomfort**: Reduce energy level for future treatments, apply soothing barrier cream. - **Hyperpigmentation (Fitzpatrick III-IV patients)**: Initiate hydroquinone 4% BID and enforce strict sun avoidance. - **Infection (rare)**: If suspected, swab for culture and initiate empirical antibiotic therapy. |
| Clinic Implementation Guidelines | - Confirm all consents are signed before treatment. - Ensure protective eyewear (for the provider) and proper ventilation in the treatment room. - Maintain precise spacing between plasma arcs to avoid excessive skin trauma. - Conduct post-treatment follow-up within 7-10 days. |
| Photographic Documentation Protocol | - Take pre-treatment photos from standardized angles (front, side, close-up views). - Take post-treatment photos immediately after the procedure and at follow-up appointments. - Store images securely in the patient’s medical record. |
| Post-Treatment Care | - Avoid touching, scratching, or picking at the treated area. - Keep the area dry for at least 24 hours post-treatment. - Allow scabs to fall off naturally within 5-10 days. - Avoid direct sun exposure for 4-6 weeks; apply SPF 50+ daily. - Use gentle post-procedure serums or healing balms to aid recovery. |
| Additional Documentation Requirements | - Signed informed consent detailing risks, benefits, and post-care instructions. - Fitzpatrick skin type assessment. - Treatment log including plasma energy settings, treated areas, and patient response. - Post-treatment care instructions provided to the patient and documented. |